WJ-05

N/A

Report date: 2025/05/27 14:25:58
NME

Base Information

Drug NameWJ-05
Drug Alias NameWJ005WJ05WJ-05WJ-005
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase WEE1 inhibitors
TargetsSerine/threonine-protein kinase WEE1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWigen Biomedicine technology (Shanghai) Co LtdShanghai Junshi Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWigen Biomedicine technology (Shanghai) Co LtdShanghai Junshi Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A